Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tried-and-True Antibiotic May Block Conversion to MS
Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Transcriptional de-repression of ERVWE1 following influenza A virus infection.
A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.
Progesterone's role in neuroprotection, a review of the evidence.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Current understanding of klotho.
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Bilateral optic neuritis after inactivated influenza vaccination.
Physical and social environment and the risk of multiple sclerosis.
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.
Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration.
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Pages
« first
‹ previous
…
369
370
371
372
373
374
375
376
377
…
next ›
last »